Correlation Between McDonalds and Zynerba Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both McDonalds and Zynerba Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining McDonalds and Zynerba Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between McDonalds and Zynerba Pharmaceuticals, you can compare the effects of market volatilities on McDonalds and Zynerba Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in McDonalds with a short position of Zynerba Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of McDonalds and Zynerba Pharmaceuticals.

Diversification Opportunities for McDonalds and Zynerba Pharmaceuticals

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between McDonalds and Zynerba is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding McDonalds and Zynerba Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zynerba Pharmaceuticals and McDonalds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on McDonalds are associated (or correlated) with Zynerba Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zynerba Pharmaceuticals has no effect on the direction of McDonalds i.e., McDonalds and Zynerba Pharmaceuticals go up and down completely randomly.

Pair Corralation between McDonalds and Zynerba Pharmaceuticals

Considering the 90-day investment horizon McDonalds is expected to generate 0.22 times more return on investment than Zynerba Pharmaceuticals. However, McDonalds is 4.55 times less risky than Zynerba Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Zynerba Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  26,084  in McDonalds on August 26, 2024 and sell it today you would earn a total of  2,944  from holding McDonalds or generate 11.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy31.99%
ValuesDaily Returns

McDonalds  vs.  Zynerba Pharmaceuticals

 Performance 
       Timeline  
McDonalds 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in McDonalds are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, McDonalds is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Zynerba Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zynerba Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Zynerba Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

McDonalds and Zynerba Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with McDonalds and Zynerba Pharmaceuticals

The main advantage of trading using opposite McDonalds and Zynerba Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if McDonalds position performs unexpectedly, Zynerba Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zynerba Pharmaceuticals will offset losses from the drop in Zynerba Pharmaceuticals' long position.
The idea behind McDonalds and Zynerba Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope